Stepan (SCL) Q1 2026 earnings review
Restructuring Charges Obscure Fundamental Margin Squeeze
Stepan Company swung to a $41.4 million net loss in Q1 2026, driven by a massive $65.4 million pre-tax restructuring charge for site closures under 'Project Catalyst'. However, underlying operations are also under significant pressure. Adjusted Net Income plunged 47% to $10.3 million, and Adjusted EBITDA fell 14% to $49.6 million. While the company eked out a 2% top-line gain, the core Surfactants segment saw a 15% drop in EBITDA due to severe oleochemical cost inflation, competitive pressures, and weather impacts. Management maintains a full-year outlook for Adjusted EBITDA growth and positive free cash flow, but severe weakness in Europe and negative Q1 cash flow indicate a steep climb ahead.
🐂 Bull Case
Project Catalyst is actively optimizing the footprint with the closure of the Fieldsboro site. The company expects these actions to create a more agile organization, and a pending $30M land sale will bolster the balance sheet.
Despite global macro weakness, North American Polymers volume grew 5%, and Specialty Products volume surged 30%. End markets like Crop Productivity and Oilfield are generating robust demand.
🐻 Bear Case
The company's largest segment, Surfactants, saw Adjusted EBITDA drop 15% despite a 5% revenue increase. Raw material inflation (oleochemicals) and competitive pressures in Mexico are eroding profitability.
European Polymers volume plummeted 19% year-over-year. This severe regional contraction dragged total Polymer segment volumes down 6% and highlights severe regional macroeconomic headwinds.
⚖️ Verdict: 🔴
Bearish. The $65.4M restructuring charge makes the headline numbers look worse than reality, but the 47% drop in Adjusted Net Income reveals real fundamental weakness. With the core Surfactants margin shrinking and European volumes collapsing, the path to achieving full-year growth looks highly constrained.
Key Themes
Surfactant Segment Margin Squeeze
Surfactants revenue grew 5% to $453.7M, but Adjusted EBITDA fell 15% to $41.1M. The company cited a severe cold snap in the U.S., production timing issues in Asia, competitive pressures in Mexico, and rising oleochemical costs. Management has so far been unable to pass these costs through to customers efficiently enough to protect the bottom line.
Project Catalyst Execution
Management took a definitive $65.4M pre-tax restructuring charge in Q1 to implement 'Project Catalyst'. This involves shutting down the Fieldsboro, NJ site and decommissioning assets in Millsdale, IL and Stalybridge, UK. While painful in the current quarter, this footprint optimization is the primary driver for future cost savings and margin recovery.
European Macro Drag on Polymers
While North American Polymers volume grew a healthy 5%, European volume collapsed by 19%. This massive regional divergence pulled total segment volume down 6% and total segment revenue down 11%. Despite the volume drop, global margin improvements allowed the segment to post an 8% increase in Adjusted EBITDA.
Strength in Specialized End Markets
Crop Productivity, Oilfield, and Industrial Cleaning proved to be highly resilient end markets. Strong demand in these areas drove a 2% organic volume increase in the Surfactants segment and fueled a massive 30% volume surge in the Specialty Products segment.
Capital Projects Hit the Income Statement
Interest expense rose to $5.0M from $4.1M a year ago. This was driven by lower capitalized interest income due to the operational start-up of the new Pasadena, TX site. While the site is necessary for future growth, the immediate impact is a drag on adjusted net income.
Other KPIs
Decelerating. Free cash flow was negative, driven by seasonal working capital requirements. Cash from operations of $16.9M was insufficient to cover $30.9M in capital expenditures. Management expects FCF to turn positive for the full year.
Decelerating severely. Down 47% from $19.3M in Q1 2025. This metric excludes the $65.4M restructuring charge, highlighting that the underlying business operations—specifically Surfactant margins and higher interest expenses—are heavily pressured.
Guidance
Reversing. After posting a 14% year-over-year decline in Q1, management's guidance of full-year growth implies a significant acceleration in the second half of the year, heavily dependent on the realization of Project Catalyst cost savings and raw material price pass-throughs.
Accelerating. Implies a reversal from the negative $14.0M posted in Q1. Management expects working capital requirements to normalize in subsequent quarters.
Key Questions
Oleochemical Cost Pass-Through
Surfactant margins were hit hard by oleochemical costs in Q1. What is the expected timeline to pass these elevated costs onto customers, and do you expect pricing power to hold up given competitive pressures in Mexico?
European Polymers Collapse
European Polymers volume plummeted 19%. Is this driven by general macroeconomic weakness in the region, or have there been specific customer losses or competitive displacements?
Project Catalyst Timeline
You took a $65.4M charge this quarter for site closures. How much of the expected structural cost savings will materialize in the P&L in the second half of 2026 versus 2027?